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  TB    - Tuberculosis 
  DM   - Diabetes Mellitus  
  WHO   -  World Health Organization  
  RNTCP  - Revised National Tuberculosis  
      Control Programme   
  OGTT   - Oral Glucose Tolerance Test  
  ADA   - American Diabetology Association  
  N   - Normal  
  IFG   - Impaired Fasting Glucose  
  IGT   - Impaired Glucose Tolerance  
  AFB   - Acid Fast Bacillus  
  ATT   - Anti Tuberculosis Treatment  
  HIV   - Human Immuno Deficiency Virus  
  CVA   - Cerebro Vascular Accident  
  GRH   - Government Rajaji Hospital 
  TNF   - Tumour Necrosis Factor 
  IL   - Interleukin  
  HbA1c  - Glycosylated Haemoglobin  
INTRODUCTION 
 
 Tuberculosis and Diabetes mellitus are among the top rated diseases in 
the Indian population, with significant effects on morbidity and mortality of the 
community, and producing a great impact on the economical aspects of the 
society. 
 
To find out the correlation and coexistence of both the diseases are very 
important as they influence the clinical course and therapeutics of each other. It 
has been postulated that in the context of economic development, a country’s 
health issues will evolve from infectious to noninfectious diseases. In reality, 
this transition more commonly simply adds chronic conditions to a public 
health system already burdened by infectious disease. In many settings, this 
process will result in the convergence of two epidemics: Diabetes and 
Tuberculosis1. 
 
 There is now recognition of an explosive epidemic called Diabetes in 
India and in this pandemic invasion of Diabetes, the diagnosed cases forms just 
a tip of the iceberg. WHO has projected that maximum increase in diabetes 
would occur in India2.  
 
 Tuberculosis and diabetes frequently coexist together and there is a 
growing amount of evidence of one disease fueling the other.  
 
 Symptoms of one disease often mimic those of the other. Loss of weight, 
loss of appetite and lassitude are common to both diseases. The association is 
more common among those above 40 yrs of age.  
 
 Diabetes appears to have an induction and aggravating effect on 
tuberculosis. Tuberculosis was found to be more pronounced in diabetes, had 
more pronounced radiological signs, treatment failures and deaths were also 
frequent .  
 
Diabetes mellitus has been reported to modify the presenting features of 
pulmonary tuberculosis but their conjoint presence does not alter the 
symptomatology, bacteriology and tuberculin reaction. Some studies have even 
indicated that MDR.TB is more common in diabetes than in non diabetic 
population.  
 
 Tuberculous patients who develop diabetes have greater clinical severity 
at the onset, a greater degree of lung involvement and residual changes.    
 
 The implications of these issues throw up numerous problems of basic, 
applied and operational nature and the possibility of drug interactions between 
the two therapeutic groups contribute a lot to the difficulty in successfully 
treating this brewing double trouble.  
 
 Since simple tests like sputum analysis and blood sugar estimation will 
make a definitive diagnosis of pulmonary tuberculosis and diabetes mellitus 
respectively, the knowledge of the degree of coexistence of these diseases 
should make the treating doctor to search for the other disease when one is 
diagnosed.  
 
 The diagnosis of coexisting diabetes in TB patients will also help in 
early treatment of the same and retardation of various complications of diabetes 
like renal impairment, CAD, stroke etc. which are important factors adversely 
affecting prognosis of patients with tuberculosis sequelae if they do occur.  
 
 Currently in India approximately 20 million people suffer from diabetes 
but less than 12% receive pharmacological treatment. It has been projected that 
by the year 2025, there would be 57.2 million diabetics in India2. Diabetics are 
high risk group for tuberculosis, especially insulin dependent patients whose 
risk is about 38 times higher than the general population.  
India is also the home to the largest number of tuberculosis patients in 
any one country. And there is a growing amount of evidence of one disease 
fueling the other. The interest in diabetes and tuberculosis is mounting rapidly 
and it promises to be an exciting time for researchers and clinicians involved in 
the study of dual diseases. There are numerous issues of basic, applied and 
operational research waiting for solutions. 
 
 It is a wake-up call for all clinicians and researchers to gear-up to meet 
the challenge of the brewing double trouble. 
 
Many studies have explored the association between diabetes and 
tuberculosis. In developed countries, studies dating to the first half of the past 
century demonstrated considerable increase in the frequency of tuberculosis 
among patients with diabetes although the proportion with co morbidity has 
ranged widely from 1.03 to 9.3%4. Other studies have shown a higher frequency 
of diabetes among individuals with tuberculosis5,6. Similar results were found in 
the few studies that have addressed this association in developing countries. 
Hence an attempt has been made through this study to identify the 
prevalence of IGT and Diabetes Mellitus among young sputum positive 
pulmonary tuberculosis patients in Madurai and to find out the significance of 
the same.  
REVIEW OF LITERATURE 
 
Historical aspects of diabetes  
 Early evidence of description of the symptoms of diabetes in Ebers 
papyrus – 1550B.C [Shafir E 1999]8.  
 
 Early description of polyuria by Imhotep 3000 B.C. [Shafir E – 1999]8 
 
 Aratecus coined the term diabetes in AD 150.  
 
 Susrutha in India described the diabetic syndrome as characterized by 
honeyed urine [Schadewaldt – H] 19879.  
 
 1914-1919- methods for analysis to measure glucose as major reducing 
substance in serum and urine were devised. [Benedict S.R – 1918]10 
 
 1869 – Paul Langerhans identified islets of Langerhans [Lagusse E. 
1984]11 
 
 1910 – Jean de Meyer coined the term insulin – for pancreatic secretion 
which was lacking in diabetes.12  
 
 1922 – Insulin was discovered by the team – Fredrick Banting, John 
Macleod, Charles Best and J.B Collip.13 
 1923 – Nobel prize in Medicine for insulin.14  
 
Definition of diabetes mellitus7 
  It is characterized by hyperglycaemia with disturbances in carbohydrate, 
fat and protein metabolism resulting from defects in insulin secretion, action 
and or both.  
 
Epidemiology of Diabetes     
 Global – The global prevalence of diabetes is estimated to increase from 
4% in1995 to 5.4% by the year 2025.15 The WHO has projected that major 
burden will occur in developing countries. There will be a 42% increase from 
51 to 72 million in the developed countries and 170% increase from 84 to 228 
million in developing countries. The countries with the largest number of 
diabetic people are, and will be in the year 2025, India, China and United 
states.15  
 
Indian scenario – A national survey of diabetes conducted in six major 
cities in India in the year 2000 showed that prevalence of diabetes in Indian 
adults was 12.1%. The prevalence of IGT was also high 14%16. A younger age 
of onset is also noted in Indians in several studies.16,17 
 
Urban–rural difference-An urban–rural difference in the prevalence 
rate was found indicating that the environmental factors related to urbanization 
had a significant role in increasing the prevalence of diabetes18. The prevalence 
of diabetes in urbanizing rural population was found to be midway between the 
rural and urban populations19. 
 
History of Tuberculosis  
 It’s a disease of great antiquity. Tuberculosis lesions have been found in 
the vertebrae of Neolithic man in Europe and on Egyptian mummies dating 
possibly from as early as 3700 BC.20 
 
 Robert Koch – first described the tuberculosis bacillus now known as 
mycobacterium tuberculosis in 1882.21 
 
 M. tuberculosis, M. bovis and M. africanum are recognised as tubercle 
bacilli. M. tuberculosis is an obligate parasite that is infectious to human other 
primates and many other mammals.   
 
Epidemiology of tuberculosis  
Global - In 1993, the World Health Organization declared Tuberculosis 
as a global emergency because of the scale of the epidemic and the urgent need 
to improve global tuberculosis control.  
 
 According to tuberculosis case notification and rates by WHO in 2005, 
three regions dominate the world wise distribution and notification i.e., South 
East region 36% African region 24% and Western pacific region 20% (Maher 
and Raviglione 2005).22 
 
Table 1: Tuberculosis case notification and rates by WHO region in 2005 
WHO region 
No. of cases 
notified 
Proportion of 
global total (%) 
South East Asia  1,487,985 36 
Africa  992,054 24 
Western Pacific  806,112 20 
America  233,648 9 
Eastern Mediterranean  188,458 6 
Europe  373,497 5 
  Source: Clinics in Chest medicine 2005  
 
 In 2005, there was an estimated 8.8 million new cases of tuberculosis 
world wide, with an incidence rate of 141 per 1,00,000 population.  
 
Indian scenario (National Tuberculosis Institute)  
 Prevalence rate of tuberculosis infection in Indian population – 30% 
 Annual incidence of rate of infection – 1% 
 Prevalence of disease 337 to 406 / 1,00,000 population.  
 Annual incidence rate of disease – 70 to 132 /100,000 population.  
TB and DM : A Brewing double trouble 
 As far back as 600 AD, the association of the two diseases (TB and DM) 
was noted by Susrutha23. Avicenna was reported to have noted this association 
more than thousand years ago24.  
 
 The relationship between Diabetes Mellitus and tuberculosis dates back 
to Roman times. Autopsies in the 18th and 19th centuries were supportive of this 
association, although the tubercle bacillus was not discovered until 1882.  
 
 Presently, an epidemic of diabetes is occurring both in developed and 
developing nations. With the recognition of this explosive increase in the 
number of people diagnosed with diabetes mellitus all over the world, a whole 
new field of issues related to interaction between diabetes and pulmonary 
tuberculosis has been thrown open25. 
 
 The global figure of people with diabetes is projected to rise from the 
current estimate of 150 million to 220 million in 2010 and 300 million in 
202526. Most cases will be of Type-2 diabetes, which is characterized by insulin 
resistance and / or abnormal insulin secretion. 
 
 The diabetic epidemic, although apparent across the world, has been 
most pronounced in non-European population, as evidenced by studies in the 
native American and Canadian communities, Pacific and Indian Ocean island 
populations, groups in Indian and Australian aboriginal communities.26  
 
 The potential for increase in the number of cases of diabetes is greatest  
in Asia. Type –2 diabetes in children, teenagers, and adolescents is a serious 
new aspect to the epidemic and is an emerging public problem of significant 
proportions.  
 
 Based on compilation of studies from different parts of the globe, the 
World Health Organization has projected that the maximum increase in diabetes 
would occur in India.26 Considering the large population and the high 
prevalence of diabetes, the burden of diabetes could be enormous. With an 
estimated 23 million today and the numbers set to increase to 57 million by 
2025, the increasing prevalence of diabetes reflects the sedentary life-style, 
excessive energy intake, reduced physical activity and obesity26.  
 
 Studies conducted in India in the last decade have highlighted that, not 
only is the prevalence of Type-2 diabetes high, but also that it is increasing 
rapidly in the urban population. Of particular interest are the results of three 
diabetic surveys conducted in Chennai in 1989, 1995 and 2000. They show a 
rising trend for diabetes mellitus and glucose intolerance. The period between 
1989 and 1995 show a 40% rise in the prevalence27. A nation-wide study 
conducted in six major cities in India in the year 2000 showed that the 
prevalence of diabetes in urban adults aged more than 20 years was 12.1%. 
Onset of diabetes occurs at younger age in Indians. The prevalence of impaired 
glucose tolerance test, which is a fore-runner of diabetes, is also increasing 
especially among the younger populations27.  
 
 It is generally accepted that pulmonary tuberculosis is more prevalent 
among diabetics than in non-diabetics. This increase in tuberculosis morbidity 
among diabetics has strongly been substantiated by studies of the incidence of 
this combination. These statistical analysis have been made either on diabetic 
patients, material being taken from the case histories, in the medical wards and 
special diabetes hospitals and in the diabetic out patient clinics, or as autopsy 
findings and tuberculosis notifications, or on the prevalence being estimated by 
the finding of diabetics among the tuberculosis patients, admitted or on the out 
patient register of sanatoria or chest clinic specially dealing with tuberculosis 
patients. The prevalence of diabetes mellitus in tuberculosis population should 
be compared with that of general population to find whether tuberculosis 
patients suffer more from diabetes or vice-versa. Such a study in fact should be 
a synchronous survey of the definite population groups for both tuberculosis 
and diabetes.  
If the percentage of tuberculosis patients among diabetics exceeds that of 
tuberculosis patients in the average population, there will also be relatively 
more cases of diabetes among patients with tuberculosis than in the total 
population and vice-versa. Unfortunately such a study is not available28. 
 
     It is also true that the basic variations are involved firstly in the source of 
diabetes or tuberculosis patients, whether out patient clinic, private practitioner, 
ambulatory or hospitalized patients, or autopsy, secondly in age, race, sex, 
weight, duration of illness, age of onset of diabetes; thirdly in geographic area, 
in diagnostic criteria used, and in inadequacy in sample size.  
 
 Studies conducted after the introduction of the glucose tolerance test in 
1950s, have shown high prevalence of impaired glucose tolerance test in 
patients with tuberculosis with rates ranging from 2 to 41%29. The use of 
different criteria for diagnosis of diabetes mellitus makes comparisons between 
the results of the studies almost impossible.  
 
There have been reports of high prevalence rates of diabetes in cases of 
pulmonary tuberculosis (4-20%) and rates are higher for impaired glucose 
tolerance test (16-29%). After anti-tuberculosis therapy, 50% of them had 
normalization of glucose intolerance. Some investigators have reported an 
association between severity of tuberculosis and abnormal glucose tolerance. 
However, no association has been found with age, family history of 
tuberculosis, ethnicity or duration of treatment.30 
 
Time relationship between TB and DM 
It is universally accepted that among the diabetics who suffer from 
tuberculous disease, it is the diabetes, which antedates the onset of tuberculosis. 
In an earlier analysis Mark and associates31 have found in a series of 349 
patients, diabetes preceded tuberculosis in 60 percent and Reaud32 reported in a 
series studied in early fifties that more than 50 percent of the patients had 
suffered from diabetes for more than 5 years. Ferrara33 reported 69 percent of 
diabetic tuberculosis patients of his series of 68 patients in whom diabetes 
antedated the tuberculosis.  
 
Boucots43 postulation that increasing prevalence of tuberculosis should 
be observed with increasing duration of diabetes could be held valuable only 
with regard to younger diabetics. The tuberculosis prevalence for those below 
40 years was 5 percent with diabetes of less than 10 years duration, compared 
to 17 percent those with diabetes of more than 10 years duration. But for those 
patients over the age of 40, the prevalence of tuberculosis was only 8 percent 
regardless of the duration of diabetes. Though the series is small, the finding 
that 56.6 percent of cases of tuberculosis had only a history of diabetes of less 
than one year, and 31.1 percent had a diabetic history of 1 to 5 years duration 
compared to 10.3 percent with diabetic history varying from 6 to 15 years in the 
series of Jha35 et al (1980) who also points to the fact that the duration as such is 
not important. Similar were the conclusions of Deshmukh et al40 (1962) and 
Patel36et al (1977).  
 
The point, which has to be emphasized is that, a known diabetic who has 
no reaction to tuberculin can have a check up at longer intervals compared to 
the ‘reactors’ who should be subjected to more strict surveillance and tests, and 
every unexplained febrile illness should be properly investigated for possible 
tuberculous foci in the lungs or elsewhere.  
 
Severity of Diabetes / TB in coexistence  
In the series of Jha et al35 51.7 percent of their cases were severely 
diabetic while 48.3 percent of cases had far advanced tuberculosis. As per the 
reports of Holden & Hiltz37 (1962) Nihalani38 et al  (1978) and Goyal39 et al  
(1978) the tuberculosis was far advanced in the diabetic they had studied. The 
comparable severity in diabetic state and the advanced lesion in the lungs were 
reported by various authors; Deshmukh40 et al (1966) in 40.34 percent, Nanda 
and Tripathy41 (1968) in 54.2 percent, Nihalani38 et al (1978) in 48.3 percent, 
severity of pulmonary tuberculosis have been assessed according to criteria laid 
down by the National Tuberculosis Association of U.S.A. 1961.  
 
Incidence by age 
Tuberculosis in the general population has a higher incidence with 
increasing age. Fitz42 reported the incidence of tuberculosis is higher in the 
elderly diabetics. This has been a constant finding in almost all the reports and 
maximum incidence is seen around forty years. Roy Chowdhary and Sen28 
reported from Calcutta maximum incidence in the age group 25-54 years, where 
as Jha et al35 in 1980 from Bokaro reported a peak incidence in the age group of 
41-50 years.  
 
Racial and gender difference  
Old concept that Negroes were immune to diabetes mellitus is false. The 
studies done by Joslin after analyzing the death rates of Whites and Negroes 
who were Industrial Policy holders of Metropolitan Life Insurance Company 
proved that there was definitely a higher incidence of diabetes among Negroes 
as compared to the White irrespective of the sex. Similarly tuberculosis had a 
fulminating course in Negroes with higher mortality ratio. But the prevalence 
rate is low. Boucot43 found in the Philadelphia Survey that the tuberculosis 
prevalence was 10 percent among the 2245 diabetic whites when compared to 
4.3 percent of the 861 diabetic Negroes. In 1955 the mortality rate as per 
Philadelphia Diabetic Survey were 25.3 per 10000 for white males and 4.6 for 
white females compared with Negroes 54.7 per 10000 for non-white males and 
36.7 non-white females. Increased prevalence of diabetes in tuberculosis 
patients was noted in studies from western workers, other workers and as well 
as Indian workers.  
 
As in the general population the males are more affected by tuberculosis 
in patients with diabetes. Diabetes has also been associated with a progressive 
shift of male predominance in pulmonary TB. Definite male preponderance in 
incidence is noted and is well comparable to the incidence of DM and TB in 
general population.  
 
Radiological aspects  
 Lower lung field tuberculosis was significantly associated with patients 
older than 40yrs, in females more than males and was more frequently observed 
in diabetes (Basuglo44et al in Respiration 2001). 
 
 Ezung T45, et al from (Imphal) found that the Type 2 diabetic 
tuberculosis patients were above 40 yrs and 11 out of 27 patients had minimal 
lesions, 7 had moderate lesion, and 9 had far advanced lesion, Cavitation in 3, 
and fibrosis in 4 patients.  
 
Diabetes mellitus does not affect the presenting features of pulmonary 
tuberculosis and the clinical presentation of TB in diabetic patients is similar to 
that in non-diabetic patients and the radiographic findings have been described 
as both typical and atypical. 
 
Some studies have suggested an increased frequency of lower lobe TB as 
well as a greater predisposition to cavitary disease. The possibility of the 
pulmonary lesion being predominantly associated with lower lung field diseases 
in older patients makes it difficult to diagnose and evaluate accurately if this is 
not borne in mind. 
 
However, studies by Parmer and Berger have shown that lower lung 
field involvement is an infrequent location of pulmonary TB, occurring in 7% 
or less of patients with active pulmonary TB. 
 
Since the association of diabetes only and none of the other factors were 
found to be statically significant, atypical radiographic presentation should be 
first investigated for the presence of diabetes. 
 
A significant observation of relevance is by Morris et al46 who found 
multiple lobe involvement as the predominant presentation of pulmonary 
tuberculosis in diabetics. 
 
 
 
 
 
Immunological aspects  
 Tsukaguchi47 et al were the first to demonstrate the production of 
cytokines interleukin – 1 beta (IL-1 beta) TNF alpha and IL 6 by peripheral 
monocytes of patients with pulmonary tuberculosis and diabetes. They observed 
that  
 
1. The production of IL-beta, TNF alpha, and IL-6 in tuberculosis patients 
were higher than that of observed in the healthy control subjects.  
2. But there were significantly lower levels in those with Diabetes mellitus 
with pulmonary tuberculosis.  
3. The production of IL-1 beta and TNF alpha in patients of DM and 
tuberculosis with poor control of Diabetic state was significantly lower 
than that observed in patients with good control.  
4. The TNF alpha production had significantly inverse-correlation to 
HbA1C in patients with diabetes and tuberculosis.  
 
Tsukagudi47 et al continued the pioneering work of cytokines in patients 
of tuberculosis, to define the immunopathologic mechanisms in patients with 
DM and TB, the production of IFN- gamma by CD4+T cells, and the patients 
were followed up longitudinally during antituberculous chemotherapy. At the 
time of diagnosis, IFN gamma production of CD4+T cells in either tuberculosis 
patients without DM (TB) or with DM was significantly lower than that in the 
healthy control CD4+T cells in tuberculosis patients with DM under poor 
control. They produced significantly less IFN-gamma than did patients with 
DM under good control. In longitudinal studies, IFN-gamma production in 
tuberculosis with good control diabetic patients returned to the control level by 
6 months, whereas the production in TB with poor control diabetic patients 
remained depressed. There was no significant relation between regimens of 
antituberculous chemotherapy and the production of IFN-gamma in all subject 
groups. IFN-gamma production was depressed in TB with poor control diabetic 
patients treated with ATT for 6 months. These results indicate that depressed 
production of IFN-gamma in TB with poor control diabetic patients is 
prolonged not due to tuberculous infection but by intrinsic defect presumably 
induced by poorly controlled DM.  
 
Theories for conjoint presence of TB & DM  
Although diabetic patients, as a group, are more susceptible to 
tuberculosis, there is no clear explanation as to why they are more susceptible. 
A probable cause for increased incidence of pulmonary tuberculosis in diabetic 
could be defects in host defenses and immune cell function.  
Immune derangements predominately involve the cell mediated arm of 
the immune system. Also, the degree of hyperglycemia has been found to have 
a distinct influence on the microbicidal function of macrophages, with even 
brief exposure to blood sugar level of 200mg% significantly depressing the 
respiratory burst of these cells. This is borne out of the observation that in 
poorly controlled diabetics, with high levels of glycosylated haemoglobin, 
tuberculosis follows a more destructive course and is associated with higher 
mortality. Multiple pulmonary physiologic abnormalities have also been 
documented in diabetics that contribute to delayed clearance of and spread of 
infection in the host. Infection with tubercle bacilli leads to further alteration in 
cytokines, monocyte macrophages and CD4/CD8 T cell populations. In 
summary, various factors have been attributed as causes for the wide prevalence 
of coexisting pulmonary tuberculosis and diabetes such as: 
 
Diabetic autonomic neuropathy leading to abnormal basal airway tone 
due to an alteration in vagal pathways and thus causing a reduced bronchial 
reactivity and bronchodilation is considered as one of the probable causes. The 
others are: 
 
Low Opsonic index, Decreased bactericidal activity, Lowered tissue 
resistance, Decreased synthesis of collagen, Impaired defensive function of RE 
cells, Increased availability of glycerol in tissues that act as substrate for TB 
bacilli, Lack of adequate substrate for antibody formation due to disturbed 
protein metabolism. Presence of gastroparesis causing varying degrees of 
impaired gastrointestinal drug absorption. 
Hyperglycaemic state influencing sub optimal tissue levels of 
medications or interfering with alveolar macrophage and CD4 cell function. 
Lowered production of interleukin -1 beta and tumor necrosis factor – alpha by 
peripheral blood monocytes. 
 
Abnormal chemotaxis, adherence, phagocytosis and microbicidal 
function of polymorphonuclear cells. Decreased peripheral monocytes with 
impaired phagocytosis. Poor blast transformation of lymphocytes. Defective C3 
opsonic function. 
 
Acute severe stress is an important cause of the development of impaired 
glucose tolerance. Impaired glucose tolerance in tuberculosis is much higher 
than overt diabetes. Various Indian studies have estimated the prevalence of 
glucose intolerance in tuberculosis to be 1.5% to 14%. 
 
Although IGT reverts to normal in a large number of cases with effective 
chemotherapy, the higher percentage with IGT is significant because, according 
to the National Diabetes Data Group of NIG, 1 to 5% of patients with IGT may 
progress to overt diabetes, annually.  
 
Theories of glucose intolerance in TB 
Theories have been put forward to explain why tuberculosis patients 
develop glucose intolerance. Bloom (1969)48 suggested that occult glucose 
intolerance predisposes to diabetes. Zack et al49 (1973) suggested that glucose 
intolerance was not merely a reaction to acute tuberculous infection but rather a 
prediabetic state. Hadden50 (1967) suggested malnutrition in tuberculosis as a 
possible cause. Acute severe stress, fever, inactivity and malnutrition stimulate 
the stress hormones epinephrine, glucagon and cortisol which raise the blood 
sugar level (Guptan et al, 2000)51.  
 
Roy Choudhary and Sen (1980)52 suggested tuberculosis of pancreas as 
the possible cause. Similarly, higher incidence of chronic calcific pancreatitis 
occur in patients of diabetic pulmonary tuberculosis leading to absolute or 
relative insulin deficiency state (Mollentz et al, 1990)53 Clinical and sub clinical 
hypoadrenalism has been described in these patients (Guptan and Shah, 2000)51. 
Plasma level of IL -1 and TNF –α are also raised in severe illness, which can 
stimulate anti-insulin responses. Age, co-existing illness and alcoholism also 
influence the host response (Fernandez et al, 1997)54. 
 
Course of Tuberculosis in diabetes Patients 
Studies reviewing their conjoint association have shown that 
uncontrolled diabetes predisposes towards the development of tuberculosis, but 
effectively treated diabetics were no more liable for tuberculosis infection than 
non- diabetics. Insulin deficiency results in impairment of both leucocyte and 
lymphocyte mediated responses to infection that improve with antidiabetic 
treatment. 
 
Diabetes reactivates latent tuberculosis. Studies have shown that the risk 
is 2 to 6 times higher than in patients without diabetes. With regard to relapses, 
it is learnt that the degree of control of Diabetes mellitus did not influence the 
relapse rates but when relapses occurred, resistant strains were more often 
encountered in diabetics. 
 
There is no evidence that treatment of active tuberculosis in patients with 
diabetes is less effective than it is in patients without diabetes. 
 
Clinical aspects of concomitant Diabetes and Tuberculosis 
Patients of tuberculosis who develop diabetes have greater clinical 
severity at the onset, a greater degree of lung involvement and residual changes. 
 
The diabetics who develop pulmonary tuberculosis have higher blood 
sugar levels and develop complications like coma and diabetic 
microangiopathies. 
 
Diabetic patients, who develop chest symptoms, need increasing insulin 
requirements or present with accelerated weight loss should prompt 
investigations to rule out co- existent pulmonary tuberculosis. 
 
Few studies have attempted to determine the presentation difference and 
the differential risks of developing tuberculosis among patients with Type 1 
versus Type 2 diabetes. Swai et al55 in Tanzania followed 1250 patients with 
diabetes and noted that 5.6% patients developed tuberculosis. This study 
showed that the prevalence of tuberculosis was greatest in: 
 
The young,  
Those with low body mass, and  
Those with Type 1 DM occurring in 8.8% compared to 2.7% of Type 2 
 DM cases, 
 
Vulnerability of Type 1 diabetes mellitus is amply evidenced in many 
reports form many parts of the world. The 10 year actual risk of acquiring 
tuberculosis was 24.2% for 116 Type 1 diabetes mellitus and 4.8% for the rest 
in one study form Chile. 
 
Tuberculosis in Type 2 Diabetes is not uncommon either, as 5 – 10% 
have pulmonary tuberculosis in developing countries. Though tuberculosis is 
more prevalent in Type 1 diabetes mellitus, the magnitude of the problem in 
Type 2 diabetes mellitus should be considered with no less concern in the 
purview of Type 2 diabetes mellitus, affecting an overwhelming larger number 
of people and also emerging as a serious public health problem in developing 
countries. 
 
Challenges in therapeutics  
A study by Bashar M et al has revealed that the proportion of cases of 
MDR – TB was significantly higher in patients with coexisting diabetes 
mellitus and this number was constant over years. But scientists who performed 
a study in a tertiary care teaching hospital in South India to evaluate the 
association of drug resistant tuberculosis in diabetic subjects have concluded 
that diabetic tuberculosis patients do not have an increased risk of 
mycobacterial drug resistance. The researchers also concluded that drug 
resistance to first line anti-TB drugs was not found to be associated with 
diagnosis or duration of diabetes mellitus. 
 
Rifampicin is a powerful inducer of the hepatic microsomal enzyme 
system and frequently interacts with other drugs, especially antidiabetic 
medications. It lowers the serum levels of sulphonylureas and biguanides. 
Hence patients with co – existing diabetes should have their doses of oral 
antidiabetic drugs adjusted upwards according to plasma glucose concentration. 
Takayasu et al observed that Rifampicin induced an early phase 
hyperglycemia which he attributed to augmented intestinal absorption and 
accelerated metabolism of oral hypoglycemic agents.  
 
Rifampicin is known to cause early hyperglycemia in non-diabetic 
patients with or without pulmonary tuberculosis, and also to augment intestinal 
absorption of glucose.  
 
Rifampicin accelerates the metabolism of anti-diabetic drugs and thus, 
per se may increase insulin requirements. 
 
Isoniazid antagonizes sulphonylureas and impair insulin release and 
action, and Rifampicin shortens the plasma half life of sulphonylureas. 
 
The earliest study of DM in pulmonary tuberculosis was done by 
Nichols56, and he postulated that a reciprocal relationship should be expected 
when these two disease entities co-exist. Some amount of glucose intolerance 
predisposes to tuberculosis and some underlying endocrine abnormality 
predisposes to latent diabetic state and tuberculosis. Roy Choudhary and Sen52 
suggested that tuberculosis of pancreas may give rise to glucose intolerance.  
 
Irrespective of the triggering mechanism(s), the fact remains that an 
epidemic of diabetes mellitus is sweeping the country. The recent prevalence 
data has propelled the estimates for India upwards-32million in 2000 and 
80million in 2030. India is also the home to the largest number of tuberculosis 
patients22.  
 
Type 2 diabetes is increasing worldwide and India is mentioned as 
diabetic capital in the diabetic map, and the reason being multifactorial. Even in 
the institution of free supervised and unsupervised multi drug chemotherapy the 
pulmonary tuberculosis so far could not be contained successfully.  
 
The possibility of the disease entity emerging itself with different 
clinical presentation eg. non cavitary pulmonary tuberculosis especially in the 
younger age group and in the elderly has been thought of. The multi drug 
resistance itself is a threat and in a situation like that of Indian scenario with 
increasing incidence of Type 2 diabetes, and with the phenomenon of multi 
drug resistant cases propping up, a serious consideration and a meaningful 
approach to the problem, and an attempt for an early diagnosis is absolutely 
mandatory to look for the possibility of diabetes in freshly detected tuberculosis 
patient and in those on treatment with ATT. All tests to confirm or exclude 
diabetes mellitus should be done as is done in those for the assessment of HIV 
status of the pulmonary tuberculosis patient as a routine.  
The clinician should suspect diabetes in TB patients, when symptomatic 
improvement is not gained with ATT and should treat diabetes aggressively if it 
is detected.  
 
From the literature available, it is to understand that the association 
of Diabetes mellitus Type 2 with pulmonary tuberculosis is a fact and not a 
fallacy.  
 
 
 
 
 
 
 
 
 
 
 
RELATED STUDIES 
 
1. Pulmonary tuberculosis in diabetics  
By Morris JT. Seaworth BJ Mc Aelister CK. Chest 1992 Aug 102 
(2)539-4146.  
In diabetes, it has been suggested that tuberculosis tends to occur 
predominantly in lower lobes. Multiple lobe involvement was the predominant 
chest roentgenographic finding in Diabetes with Pulmonary Tuberculosis.  
 
2. Does diabetes alter the radiological presentation of pulmonary 
tuberculosis  
    Shaikh MA. Singla R, Khan NB, Sharif NS, Saigh MO. Chest 1994 
Jul 106 (1) : 32657.  
 Pulmonary tuberculosis with diabetes mellitus group are more likely to 
present with atypical radiological images.  
 
 Among diabetic patients presenting with lower lung field lesions or 
cavities possibility of tuberculosis should always be considered for prompt 
diagnosis and management.  
 
 
 
3. Tuberculosis and diabetes  
 D.C. Lahiri and P.K. Sen (From B.C. Roy Research Institute, 
Calcutta). Indian J. Tub.Vol. X, XI, No.2, 197458.  
 The prevalence of diabetes is 6.5% in tuberculosis population.   
 
4. Pulmonary tuberculosis and diabetes  
 P.A. Desh Mukh and T.Shaw Ind. J. Tub. 1984, 31, 11459.  
 The incidence of tuberculosis in DM was 5.6%. Routine post breakfast 
urine sugar or blood glucose examination should be done in all pulmonary 
tuberculosis patients to find out association of DM. 
 
5. Diabetes mellitus and pulmonary tuberculosis  
 S.R. Tripathy et al Ind. J. Tub. 1984, 31, 12260.  
 The prevalence of pulmonary tuberculosis is 4.1% of known diabetic 
patients. The prevalence of diabetics among pulmonary tuberculosis patients is 
3%. 
 
6. Prevalence of diabetes mellitus among patients with pulmonary 
tuberculosis  
  Research committee of tuberculosis association of India. Ind. J. Tub. 
1987, 34, 9161.  
 The prevalence of DM among tuberculosis patients is considerably 
higher than general population. The rate is higher in patients above the age of 
40.  
7. DM – TB – The brewing double trouble by Lalit Kant.  
 Ind. J. Tub. Vol 50No.4, Oct. 200362. 
8. Older Studies  
Banyai (1931) reported that 0.59 per cent of 5.225 tuberculous 
admissions were found to have diabetes63. 
Wiener and Kavee (1936) reviewed previous incidence of 0.25 per cent 
to 0.66 per cent diabetes among tuberculous patients, although they reported 
that 6.4 per cent of their own 3,385 tuberculous admissions had diabetes64.  
Rest (1941) reported an incidence of 0.025 per cent diabetes in 1,360 
tuberculosis admissions in a sanatorium for Jewish patients65. 
Israel and Payne (1940) found 2 per cent diabetes among 610 
tuberculous patients66. 
Banyai and Cadden in 1944 reviewed previous reports concerning the 
incidence of diabetes among tuberculous patients showing rates of 0.31 percent 
in 4,500 patients (Tompkins 1929) 0.7 per cent in another 3,963 patients 
(Banyai 1931) and 1.6 per cent in 5,575 patients in a 13 – year study of their 
own67. 
Among 2,366 tuberculous admission in the city of Honston Tuberculosis 
Hospital in the period 1940 to 1950, only 0.63 per cent were found to have 
diabetes (Speck et al 1952)68. 
Ferrara (1952) found 2.1 percent diabetes among, 178 tuberculous 
admissions form 1937 to 195069. 
Reaud (1953) cited previous rates of 0.17 to 1.6 percent diabetes among 
tuberculous patients and 0.98 percent diabetes among 3,850 sanatorium 
admission from 1950 to 1952. However, he referred to one of the highest rates 
of diabetes, reported in tuberculous patients – 14.23 percent diabetes among 
predominantly Jewish patients in Montefiore Hospital in New York70. 
 Nichols (1957) conducted diabetic screening in the form of a modified 
glucose tolerance test on 305 subjects. 178 of these subjects comprised of a 
uniform group of young otherwise healthy military men hospitalised for 
tuberculosis. Follow up testing showed that 22 per cent of later group presented 
various abnormalities of glucose tolerance and that at least 5 per cent were mild 
diabetic. Although these figures probably indicated the maximal incidence of 
diabetes in the group examined, but if other accepted criteria for the diagnosis 
of diabetes were substituted for the criteria used here, then the incidence of 
diabetes might be listed as 9 per cent, 11 per cent or 18 per cent rather than 5 
per cent56.  
Table 2: Impaired glucose tolerance tests in patients of pulmonary 
tuberculosis 
Author Year 
No. of 
tubercular 
patients 
Prevalence of 
diabetes /IGTT 
Khanna71  1968 150 6.6% 
Bloom5  1969 47 34% 
Kishore et al72  1973 90 20.9% 
Zack et al49  1973 256 41% 
Lahiri and Sen58  1974 851 66% 
Roychoudhary et al52  1980 961 27.25% 
Marais73  1980 436 2.1% 
Gulbas et al74  1987 30 13.3% 
Olyboyo and Erasmusl9  1990 54 3.7% 
Mugusi et al75  1990 506 6.7% 
Jawad et al76  1995 106 49% 
Fernandez et al54  1997 300 9.3% 
Lin et al77  1998 - 4.86% 
Basoglu et al44  1999 58 19% 
Chukanuva et al78  2000 69102 0.34% 
Yamagishi et al79  2000 4169 14.1% 
Firsova et al80  2000 130 10.8% 
Guptan and Shah51 2000 - 9.7% 
MK Jain et al81  2003 106 16.98% 
 
 
Gajanan Gavde82, in his clinical review gives the comparative 
proportions of pulmonary tuberculosis found in diabetics and diabetes found in 
cases of pulmonary tuberculosis by different authors.   
Table 3 
 
Authors PT in DM% DM in PT% 
Jamaica report   0.9 
Patel et al36  5.7 - 
Deshmukh et al40  8.3 - 
Philadelphia report43  8.4 - 
Ross 30.0 20.0 
Chittaranjan Kal et al  24.2 - 
Nichols56  - 22.0 
Bahulkar et al  - 26.3 
Roy Choudhary et al52  - 27.2 
Holden Hiltz37  45.3 37.7 
 
 PT – Pulmonary tuberculosis, DM – Diabetes mellitus  
 
 
 
AIM 
 
- To assess the prevalence of diabetes and IGT among newly detected 
young sputum positive tuberculosis patients.  
 
- To assess the radiological profile of such cases.  
 
- To analyze the gender difference.  
 
- To suggest workable guidelines to detect diabetics mellitus among 
tuberculosis population.  
 
 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS 
 
Type of study   : Cross sectional study  
Setting    : Dept of Medicine, GRH, Madurai.  
Collaborating Dept.  : Dept. of Thoracic Medicine,  
Dept. of Diabetology  
Duration of study   : 1 year August 2005 – July 2006  
Ethical Clearance   : Obtained, a copy is enclosed in annexure I 
Consent    : Informed consent was obtained  
Inclusion criteria   : Newly diagnosed young (age 25-45)  
     sputum positive tuberculous patients of  
     both sexes who were conscious cooperative  
and free of overt comorbid illness were 
considered for the study. 
Exclusion criteria   : Patients who had any of the following were  
     excluded from the study.  
1. Age <25 - > 45    2. HIV positive  
2. Known diabetic   4. BMI >25  6. Hypertensives 
3. Patient with thyroid or adrenal disorders  
4. Acute conditions  
a. Acute myocardial infarction  
b. Acute CVA 
c. Acute medical emergencies  
5. Patients with malignancy  
6. Bed ridden patients  
7. Psychiatric patients  
8. Uncooperative patients  
9. Pregnant women 
10. Women on oral contraceptive pills  
11. Patients who are alcoholic / smokers  
12. Patients who are on drugs-steroids, β blockers diuretics etc 
13. Family history of diabetes   
 
MATERIALS  
 A total of one hundred and twenty two consecutive patients of newly 
diagnosed young sputum positive tuberculosis patients attending the outpatient 
clinic of Department of Thoracic Medicine GRH, Madurai were included for 
this present study on the basis of a set of inclusion and exclusion criteria out of 
780 patients seen. The exclusion of other patients is given in figure 1 below.  
 
Figure 1: Patient flow chart 
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patients 
Patients 
excluded from 
study   
Known diabetic - 
90   
148-HIV positive 
Alcoholic- 22  
Family history - 30 
40-Smokers 
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METHODS  
 Selected sociodemographic, laboratory and radiological data were 
elicited from these patients and recorded in the proforma.  
1. Socio demographic data  
¾ Age  
¾ Sex  
152 
patients 
122 
patients 
Did not complete  
investigations -30 
Age>45- 72   55-Age<25 
Hypothyroidism -4   19 –BMI >25 
Other comorbid 
illness - 29   
25-On drugs  
Hypertensives – 45   23-pregnant 
women 
Psychiatric patients  
– 5  
13-Bed ridden 
patients 
¾ Domicile – Rural / Urban  
2. BMI 
3. Radiological data  
Chest X ray of all patients were taken and reports included.  
4. Laboratory Data  
¾ GTT – was done in all patients. Blood sugar was measured using 
COBAS autoanalyser.  
¾ Sputum for acid fast bacilli by Ziehl Nielsen technique.  
5. Conflict of interest – Nil  
6. Financial support – This study did not receive any financial support  
   from any organization  
7. Statistical analysis – Data were entered in a predetermined proforma 
and later entered into a Microsoft excel spread sheet and analysed using 
chi square test and t test.  
 
LIMITATIONS OF THE STUDY 
 
1. As the inclusion criteria were rigid, the true numbers of cases will be 
more than the number of cases reported daily during the study period.  
 
2. HbA1C could not be done due to technical constraints.  
 
3. Follow up of patients in IGT-group was not done because of practical 
difficulties.  
 
4. Target organ damage assessment of those patients detected with diabetes 
was not done as they were beyond the scope of this study.  
 
 
 
 
 
 
 
 
 
 
DEFINITIONS USED FOR THE STUDY PURPOSE 
1. Sputum positive tuberculosis (RNTCP guidelines)  
 Patients with at least 2 sputum samples positive for AFB by microscopy 
and those with one sputum sample positive and radiological abnormalities 
consistent with active pulmonary  tuberculosis.     
2. Age definition by WHO 
  Young   25-45  
  Middle age   45-65 
  Elderly   >65  
3. OGTT7 
 The OGTT should be administered in the morning after the patients had 
had at least 3 days of unrestricted diet (>150 g of carbohydrate daily) and usual 
physical activity. The test should be preceded by an overnight fast of 10 to 16 
hours, during which the patient may drink water. The patient may not smoke 
during the test. Factors that may influence interpretation of the results of the test 
should be recorded (e.g., medications, inactivity, infection). Such factors should 
be taken into account in interpreting the results of the test. 
 After the fasting blood sample is collected, the subject should drink 75g 
of anhydrous glucose (or partial hydrolysates of starch with an equivalent 
carbohydrate content) in 150 to 300 of water over the course of 5 minutes. 
Blood samples are drawn before (fasting) and 2 hours after the load. 
4. ADA 2003 recommendations of hyperglycemia7 
 Categories of Hyperglycemia According to Venous Plasma Glucose 
Concentrations. 
Table 4 
Fasting Plasma Glucose Level 
 Normal Impaired Diabetes  
2-Hour postload <100mg/dl 100-125 mg/dl ≥126 mg/dl  Not done 
plasma glucose 
level 
<5.5 mmo1/L 5.6-6.9 mmol/L ≥ 7.0 mmol/L 
<140 mg/dl 
(<7.8 mmol/L) 
140-199 mg/dl 
(7.8-11.0 mmol/L)  
≥ 200 mg/dl 
(≥11.1 mmol/L 
Not done 
Normal 
 
IGT 
 
Diabetes 
 
Normal 
IFG 
 
IFG/IGT 
 
Diabetes 
 
IFG 
Diabetes 
 
Diabetes 
 
Diabetes 
 
Diabetes 
Normal 
 
IGT 
 
Diabetes 
 
Unknown 
     Weight  
5. BMI  = 
  (Height in m)2 
6.  X-ray Zones –  
¾ Upper Zone - 1st and 2nd  intercostal space 
¾ Mid Zone  -  3rd and 4th intercostal spaces 
¾ Lower Zone -  Rest of intercostal spaces 
RESULT ANALYSIS 
 
Table 5 
Distribution of cases in relation to Age 
Age Male Female Total 
25-30 19 16 35 
31-35 12 8 20 
36-40 16 7 23 
41-45 34 10 44 
Total 81 (66.39%) 41 (33.6%) 122 
 
Study group contains 66.39% Males and 33.6% Females. Age and 
gender wise analysis of the study population shows males are more affected 
with TB than females. 36% of the study population falls in the 41-45 age 
category indicating increased incidence of sputum positive TB in that age 
group.       
Table 6 
Statistical Analysis of age and gender 
 Male  Female  Total 
Mean 37.19 34.20 36.81 
SD 6.57 7.06 6.86 
Range 25-45 25-45 25-45 
Blood Sugar Analysis 
  
Out of 122 patients studied, 57 had normal blood sugar, 6 patients had IFG, 38 
had IGT, 21 had DM, as per the ADA Grading of OGTT results. 
 
Table 7 
GTT Results  
ADA Male Female Total 
N 36 (29.5%) 21(17.21%) 57(46,72%) 
IFG 3(2.4%) 3(2.4%) 6(4.9%) 
IGT 27(22.13%) 11(9.0%) 38(31.14%) 
DM 15(12.29%) 6(4.9%) 21(17.21%) 
 
 
 This study revealed that 53.28% of the patients had abnormal blood 
sugar values in the form of IFG – 4.9% IGT – 31.14% DM-17% where as 
prevalence of IGT in normal population in Tamilnadu – was 14% and DM was 
13.4% (Ramachandran et al) 
 
 
 
Table 8 
Statistical analysis of IGT results 
Proportion ADA 
Grade Study Group Normal Population 
t value p value 
IGT 0.3115 0.1400 3.1507 0.0011 
DM 0.1721 0.1350 0.7683 0.4431 
  
 The IGT in the study group was higher than the normal population with 
definite statistical significance p < 0.05. But Diabetes in the study group didn’t 
show any statistical significance when compared normal population p > 0.05. 
 
Table – 9 
 IGT DM 
Proportion 0.3115 0.1721 
P 0.0106  
 
 This table shows that the prevalence of IGT is more than diabetes in the 
study group and p value significant  p = 0.0106. 
 
 
 
 
 Result of OGTT were further analyzed on the basis of Age / Gender 
Age wise analysis 
Table 10 
Age wise analysis of OGTT results  
ADA Grade  
Age Group N IFG IGT DM 
25-30 23 3 7 2 
31-35 8 1 10 1 
36-40 13 0 8 2 
41-45 13 2 13 16 
Total 57 6 38 21 
 
 Analysis of age in different groups with reference to the GTT results 
revealed that 55.2% of IGT (n=38) and 85.7% of DM (n=21) occurred in the 
36-45 age group showing that increased coexistence of TB and IGT and DM in 
this age group.  
Table - 11 
Gender wise Analysis 
ADA Grade Male Female Total  
N 36 21 57 
IFG 3 3 6 
IGT 26 11 38 
DM 15 6 21 
Total 81 41 122 
Table - 12 
Age and Gender wise Break up of OGTT results  
 
Males Females 
Age 
N IFG IGT DM N IFG IGT DM 
25-30 12 1 5 1 11 1 2 1 
31-35 5 1 5 1 3 0 5 0 
36-40 9 0 5 2 4 0 3 0 
41-45 10 1 12 11 3 1 1 5 
 
 
 
Table - 13 
Statistical Analysis of Gender difference of DM / IGT 
 
 M F P 
DM 0.1852 0.463 0.5804 
IGT 0.3311 0.2683 0.4551 
 
 
 There is no statistically significant difference in the IGT, or DM among 
males / females and P value > 0.05 in significant. 
 
 
 
 
Analysis of Radiological Finding 
 
Table 14 
X – Ray Zone involvement  
 
Right Left 
Zone 
M F Total M F Total 
Upper Zone 35 21 56 29 11 40 
Mid. Zone 3 0 3 1 1 2 
Lower Zone 2 4 6 3 1 4 
Multiple Zone 10 2 12 7 3 10 
 
 
Table 15 
Correlation of X-ray zone involvement with GTT results 
 
Zone N IFG IGT DM 
Upper Zone 34 3 28 10 
Mid. Zone 3 0 0 2 
Lower Zone 4 2 3 1 
Multiple Zone 9 1 5 7 
 
 61% of the study group showed upper zone involvement and when 
correlated with GTT results. 59% of N (n=59) 50% of IFG (n=6), 73.6% IGT 
(n=38) and 47.6% of DM (n=21) cases showed upper zone involvement.  
Table 16 
Statistical Analysis of X-ray zone involvement (Upper zone) – correlated 
with IGT and DM 
 Male  Female Total 
DM 0.1406 0.1250 0.1354 
IGT 0.3750 0.3438 0.3646 
P 0.0021* 0.0365* 0.0002* 
 
This clearly shows that upper zone lesion predominate in both IGT and 
DM in both genders and the p value is statistically significant p(< 0.05). 
Table 17 
Analysis of Lesions in chest X-ray 
 
Lesions Right Left Total Percentage 
Infiltrate  61 41 102 72.34% 
Consolidation  6 3 9 6.38% 
Cavity  18 3 21 14.89% 
Effusion  5 2 7 4.96% 
Hydropneumothorax  2 2 4 2.13% 
Total  92 51 142*  
 
* Total no of lesions is more than sample size because multiple lesions were 
observed in some patients. Infiltrates were the commonest lesion documented 
(72.34%) in the study group.   
Table - 18 
Analysis of lesions in X-ray according to Age – Right 
 
Age 
group 
Infiltrates Cavity Consolidation Effusion
Hydropneumo 
thorax 
25-30 18 4 1 0 1 
31-35 12 1 1 2 0 
36-40 7 5 2 2 0 
41-45 24 8 2 0 1 
Total 61 18 6 4 2 
 
Table - 19 
Analysis of lesions in X-ray according to Age – Left 
 
Age 
group 
Infiltrates Cavity Consolidation Effusion 
Hydropneumo 
thorax 
25-30 12 2 3 0 0 
31-35 4 0 0 1 0 
36-40 9 1 0 0 0 
41-45 16 0 0 1 1 
Total 41 3 3 2 1 
 
 Analysis of lesion according age group shows that infiltrates are 
common in all age group when compared to other lesions.  
 
Table - 20 
Analysis of lesions according to blood sugar values – Right 
 
ADA Grade 
Lesions 
N IFG IGT DM 
Infiltrates 27 (62%) 2 (50%) 23 (74%) 9 (64%) 
Cavity 10 (25%) 1 (25%) 3 (9%) 4 (28%) 
Consolidation 4 (9%) 0 1 (3%) 1 (7%) 
Effusion 2 (4%) 0 3 (9%) 0 
Hydropneumo Thorax 0 1 (25%) 1 (3%) 0 
Total  43 4 31 14 
 
Table 21 
Analysis of Lesions according to Blood Sugar value – Left 
 
ADA Grade 
Lesions 
N IFG IGT DM 
Infiltrates 16 (76.4%) 3 (100%) 14 (82%) 8 (80%) 
Cavity 1 (4.7%) 0 1 (5.8%) 1 (10%) 
Consolidation 3 (14.2%) 0 0 0 
Effusion 1 (4.7%) 0 1 (5.8%) 0 
Hydropneumothorax 0 0 1 (5.8%) 1 (10%) 
Total  21 3 17 10 
  
Infiltrates dominate as the major lesion in all the ADA grades as shown 
in the Tables above  
Table – 22 
Domicile 
ADA grade Urban Rural Total 
Normal 15 42 57 
IFG 4 2 6 
IGT 30 8 38 
DM 15 6 21 
Total 62 60 122 
 
 62 of the study population belonged to urban domicile and 60 to rural 
domicile. 79% of urban population had abnormal results [IFG – 6.4%, IGT – 
48.3%, DM – 24.19%] when compared to 26.6% in rural population.  
 
Table 23 
Statistical analysis of Rural Urban Variation 
 
 Urban Rural t value p value 
IGT 0.4516 0.1667 3.5873 0.0005* 
DM 0.2419 0.1000 2.1257 0.0356* 
 
 The statistical analysis shows that both IGT and DM were common in 
urban population with the significant p value < 0.05*. 
Table 24 
Statistical analysis of BMI 
 
 Male Female Total 
Mean 22.74 22.08 22.76 
SD 2.00 1.47 1.83 
Range 20-24 20-24 20-24 
 
 Mean BMI was slightly above the predicted BMI of South Indian 
population (18-22). Statistical analysis among ADA grades didn’t show any 
significant difference p value was > 0.05. 
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
 
 Tuberculosis is a highly prevalent disease in developing countries – 
particularly in India. Among Indian population it is estimated that 1-2% of 
population are suffering from tuberculosis. Diabetes mellitus is also increasing 
among Indian and Asian population and WHO estimates that 30 millions of 
Indians will have diabetes by 2025 and current prevalence of diabetes mellitus 
in Tamilnadu is about 14%. 
 
Already various reasons for predisposition of individuals to tuberculosis 
as well as diabetes mellitus have been described. Now it is clear that diabetics 
are prone for tuberculosis hence periodic studies on their association will help 
us do find out the changing trends.  
 
Present study analyses OGTT results in tuberculous patients. 31.14% 
had IGT and 17.2% had DM and the total number of patients with abnormal 
blood sugar values (IFG, + IGT + DM) account for 53.28% of the study group. 
Recent studies over the past 5 years have shown variable results for IGT in TB. 
 
 
 
Table 25 
Recent studies showing IGT prevalence in TB 
 
Study No. of Pts 
Prevalence of 
IGT 
Chukanava et al (2000)77 69102 034% 
Yamagishi et al. (2000)78 4169 14% 
Firsova et al (2000)79 130 10.8% 
MK Jain et al (2003)80 136 16.98% 
Present study  122 31.14% 
 
Various authors have suggested the mechanisms of impaired glucose 
tolerance among tuberculous patients.  
 
Bloom (1969)48 suggested that occult glucose intolerance predisposes to 
diabetes. Zack et al49 (1973) suggested that glucose intolerance was not merely 
a reaction to acute tuberculous infection but rather a prediabetic state. Hadden50 
(1967) suggested malnutrition in tuberculosis as a possible cause. Acute severe 
stress, fever, inactivity and malnutrition stimulate the stress hormones 
epinephrine, glucagon and cortisol which raise the blood sugar level (Guptan et 
al, 2000)51. Clinical and sub clinical hypoadrenalism has been described in 
these patients (Guptan and Shah, 2000)51. Plasma level of IL -1 and TNF –α are 
also raised in severe illness, which can stimulate anti-insulin responses. Age, 
co-existing illness and alcoholism also influence the host response (Fernandez 
et al, 1997)54. 
 
The increased prevalence of IGT in the present study can be explained 
by increase in IGT among general population due to reasons like urbanization, 
sedentary life style, eating habits etc. But the IGT is significantly high in TB 
population -31% when compared to 14%in normal population and p value is 
significant <0.05 
 
The present study shows that IGT in tuberculosis patients is two times 
higher than general population. 
 
The prevalence of diabetes mellitus found in this study is 17.21% and is 
high compared to 13% in the general population of Tamilnadu belonging to the 
same age group; even through the p value is not significant. 
 
In view of the increased prevalence of diabetes mellitus in tuberculosis 
population it is suggested that all tuberculosis patients should be evaluated 
clinically and biochemically for diabetes mellitus as detection and control of 
diabetes mellitus will help to achieve better tuberculosis control. 
 
 
 
Table 26 
Age group in relation to GTT results 
Age  IGT DM 
25-35 44% 14.3% 
36-45 55.3% 85.7% 
   
 Present study also reveals an important point that IGT was almost 
equally distributed in the study population regardless of age, whereas DM, was 
more in >35 age group . It can be derived from these results that prevalence of 
IGT is increasing among young Indian population, and is also significantly 
more among the tuberculous patients and they should be followed up as 50% of 
patients in the IGT group will develop diabetes. IGT is a well established risk 
factor for diabetes and coronary artery disease and this fact should be kept in 
mind. 
 Of the diabetics detected in this study, 85.7% were above 35 years of 
age, and the fact that advancing age, favors the coexistence of diabetes and 
tuberculosis is again proved here. 
 Male patients were almost twice the number of female patients in this 
study (81 vs 41). The gross variation of increased male prevalence for 
tuberculosis may be related to their increased exposure to tuberculosis and 
habits like smoking leading to increased susceptibility. Also alcoholism which 
leads to under nutrition and suppression  of immune system may contribute to 
this malady. But the GTT results didn’t show any significant variation 
according to gender in this study. 
Radiological manifestations 
 Considering the zone of tuberculosis involvement in the study group 
upper zone involvement was predominant, regardless of the glycaemic status. 
 61% of the study group shows upper zone involvement. According to 
ADA grade, upper zone inv in this study is as follows. 
 
Table 27 
Upper zone involvement 
ADA Grade 
Upper zone 
involvement 
Percentage Total 
N 34 59 59 
IFG 3 50 6 
IGT 28 73.6 38 
DM 10 47.6 21 
 
 
As far as the lesions are considered, infiltrates were the commonest 
lesion observed in the study group regardless of blood sugar values.  
 
 
Table 28 
Percentage of infiltration  
ADA Grade Right % Left % 
N 62 76.4 
IFG 50 100 
IGT 74 82 
DM 64 80 
 
Older studies have suggested an increased frequency of lower lobe TB as 
well as greater predisposition to cavitary lesion. This was reported more in the 
older patients. However studies by Parmer and Beyer have shown that lower 
lung field involvement is an infrequent location of pulmonary TB, occurring in 
7% or less of patients with active pulmonary TB. Infiltrates are reported as 
predominant lesion in 22.58% by M.K. Jain et al 2003.  
The average BMI of the patients in the study group was 22.74 in males 
and 22.08 in females. As BMI >25 was considered as exclusion criteria to 
eliminate a possible bias due to metabolic syndrome, naturally all the study 
patients will have BMI < 25, but the average was around 22 and there was no 
statistical correlation between IGT or DM and increased BMI. This can be 
explained by the fact that majority of patients attending our hospital belong to 
low socioeconomic status and the common factor of malnutrition and poor 
access to medical facilities may account for the above observation and also to 
the development of hitherto uncommon malnutrition related diabetes in both 
IGT and normal group. Zack et al49 (1973) Mugusi et al75 (1990) also found no 
significant difference in BMI among the two groups.  
 
Domicile 
 50.8% of study population belonged to urban domicile and 49.2% 
belonged to rural domicile in the present study. 
  
 Urban Rural 
IGT 48% 13% 
DM 24% 10% 
 
 IGT and DM was more among urban population. Statistically also the 
increased prevalence was significant P< 0.05. This process can be explained by 
overcrowding, life style modification and change in dietary habits promoting 
the conjoint presence of the brewing double trouble. This again reflects the 
conclusions of Ramachandran et al regarding prevalence of IGT and DM in 
urban population19.   
Tuberculosis occurring in the elderly age group has been claimed to be 
an important indicator of some underlying predisposing cause, the most 
important of which is diabetes. While diabetes in the elderly tuberculosis 
patients has received considerable attention in the past, the attention is now 
being focused more and more towards the younger age groups. It is being 
realized that perhaps, the important pathogenic factor in the development of 
tuberculosis, even in the younger age group, could be a pre-diabetic state in 
some cases at-least. These instances, could lead to precipitation of frank 
diabetes. Such cases might be detected if properly investigated. 
A significant group of young tuberculous patients may continue to 
remain in prediabetic state and some of these cases even though going into a 
phase of frank diabetes in the later stage may remain completely undetected. 
The author tried to analyze the above mentioned fact and it is very well 
proved by the results of the study.  
 
 
 
 
 
 
 
 
 
 
CONCLUSION 
 
 Prevalence of Impaired Glucose Tolerance in Tuberculous population of 
Madurai – was 31%, and it was significantly higher than in the general 
population.  
 Prevalence of Diabetes Mellitus in Tuberculous population of Madurai – 
17% was also significantly higher than in the general population.  
 IGT was equally distributed in the study population regardless of age, 
whereas DM, was more in >35 age group.  
 The prevalence of coexisting diabetes mellitus and tuberculosis was 
more common among persons aged >35.  
 In the present study tuberculosis was found to be more among males.  
 Radiologically upper zone involvement was common in normal, IGT, as 
well as DM groups.  
 Infiltrate was the predominant lesion in all the three categories – normal, 
IGT and DM.  
 No significant gender difference was observed in glycaemic status of TB 
patients in this study.  
 
 
 
SUGGESTIONS 
 
 It is worth remembering that early diagnosis of this combination of 
diabetes mellitus and tuberculosis is not that easy. When a combination of 
diabetes mellitus and tuberculosis is diagnosed either diabetes or pulmonary 
tuberculosis or both are already in the advanced stage and that makes 
management more difficult and thus the clinical outcome is rather poor.  
 
 From this study the following suggestions are made.  
 
 The only way to recognize this dreadful combination is to insist on  
 
a. Routine blood sugar (fasting and post prandial) screening test in 
tuberculosis patients atleast for all persons above 35 years.  
b. Follow up of patients with IGT – once a year for a future diabetes.  
c. Chest X-ray has to be taken in a diabetic once a year as a routine  
d. Sputum AFB, X-ray chest should be done in the following situations. 
i. more rapid weight loss  
ii. insulin requirement suddenly goes up   
iii. when cough persist for more than 3 weeks  
 
SUMMARY 
 
 Tuberculosis is prevalent in developing countries where the incidence of 
diabetes is also increasing. The relationship among these two diseases is well 
known. As tuberculosis exerts stress, it is expected that susceptible pulmonary 
tuberculosis patients can develop diabetes mellitus. Keeping these concepts in 
mind, it was aimed to find out the prevalence of diabetes mellitus and IGT 
among pulmonary tuberculosis patients attending thoracic medicine unit of 
Government Rajaji Hospital, Madurai. Also it was planned to study their 
radiological aspects and finally to provide guidelines to detect one in another.  
 Thus 122 young sputum positive pulmonary tuberculosis patients 
attending out patient clinic of Thoracic Medicine Department of Government 
Rajaji Hospital, Madurai, who satisfied rigid inclusion and exclusion criteria 
were involved in this study and all the patients underwent oral glucose tolerance 
test.  
 32 of the 122 patients had IGT and 21 patients had diabetes mellitus. 
Thus the prevalence of IGT was 31.14% and diabetes mellitus was 17.21% 
among young sputum positive pulmonary tuberculosis patients. Males were 
predominantly affected by pulmonary tuberculosis almost twice as females, but 
the OGTT results didn’t show any significant gender difference in glycaemic 
status.  
 IGT was equally distributed in the study population regardless of the 
age, but diabetes was more common in >35 age group, showing increased 
prevalence of IGT among young Indian population. Regarding radiological 
finding, upper zone involvement was common p=0.0002 with infiltrates as 
predominant lesion (72.34%) in this study. Of the 122 patients 62 were of urban 
domicile and 60 were of rural domicile. Both, IGT and diabetes mellitus were 
significantly more in urban population with p value of 0.0005 and 0.0356 
respectively.  
 BMI of the patients with IGT and diabetes mellitus didn’t show any 
significant deviation from normal value probably because of the loss of weight 
produced by tuberculosis, also patients with BMI >25 were excluded from the 
study to rule out possible metabolic syndrome. Present observations show that 
there is a rising trend of IGT and diabetes mellitus among tuberculosis 
population when compared with previous study results from India and abroad. 
Possible mechanisms of coexistence of the two and the need for screening of 
these susceptible individuals were highlighted.           
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Correlation of X-ray zone involvement 
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CHEST X-RAY IN A PATIENT WITH IGT 
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 APPENDIX - II 
PROFORMA 
A STUDY ON GLUCOSE TOLERANCE TEST IN YOUNG 
SPUTUM POSITIVE TUBERCULOSIS PATIENTS 
 
Personal Data :  
Name    : 
Age   : 
Sex   : 
Address  : 
Income   : 
Family History : 
a. TB  
b. DM  
Other comorbid conditions  
BMI   : 
Sputum AFB  : 
Chest X-ray   : 
GTT:  Blood Glucose   
Fasting   
1 hr PP 
2 hr PP 
APPENDIX III 
MASTER CHART KEY 
 
 
1. Sex   M – Male   F – Female  
2. GTT result  BSF – Blood Sugar Fasting  
   1 hr PP – 1 hour post prandial  
   2 hr PP – 2 hour post prandial  
3. ADAGr. – American Diabetology Association Grade  
4. X – ray    
 Side   R – Right   L – Left  
 Zone   1- Upper zone  2 – Mid zone  3 – Lower zone   
 Lesion  Infilt – Infiltrates  Con – Consolidation  
   Eff. – Effusion  Hydrop – hydropneumothorax  
5. BMI – Body Mass Index  
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Sl.NO AGE SEX B.S.F 1HrPP 2HrPP ADA Gr.
SPUTUM
A
SPUTUM
B
SPUTUM
C ZONER ZONEL LESIONR LESIONL BMI
1 34 M 89 146 160 IGT 1+ 1+ 1+ 1 INFIL 20
2 32 M 82 126 146 IFG/IGT 1+ 1+ 1+ 1 INFIL 24
3 33 M 72 134 166 IGT 1+ 1+ 1+ 1 INFIL 23
4 44 M 148 168 200 DM 3+ 2+ 1+ 1 INFIL 20
5 40 F 70 100 120 N 1+ 1+ 2+ EFF 22
6 38 M 72 105 126 N _ve 1+ 1+ 1 2 INFIL INFIL 28
7 42 F 111 133 125 IFG 1+ 1+ _ve 3 3 INFIL INFIL 24
8 40 F 107 180 193 IGT 2+ 2+ 1+ 1 1 CAVITY INFIL 23
9 33 M 69 151 140 IGT 1+ 1+ 1+ EFF 21
10 44 M 148 168 200 DM 3+ 2+ 2+ HYDROP 22
11 30 F 68 120 120 N _ve 1+ 1+ 1 CAVITY 25
12 45 F 140 280 312 DM 3+ 1+ 2+ 1 2&3 CAVITY INFIL 23
13 42 M 62 122 138 N _ve 1+ 1+ 1 INFIL 23
14 29 M 76 106 123 N 1+ 1+ _ve 1 CON 24
15 40 M 78 128 148 IGT 1+ 1+ 1+ 1 INFIL 21
16 26 M 75 121 130 N 1+ 1+ 1+ 1&3 INFIL 21
17 30 F 100 148 168 IGT 2+ 3+ 3+ 3 INFIL 22
18 38 F 92 197 140 IGT 1+ 1+ 1+ 1 INFIL 23
19 39 M 109 132 126 N 1+ 1+ 1+ 1 INFIL 22
20 42 M 72 138 166 IGT _ve 1+ 1+ 123 INFIL 24
21 40 M 80 106 120 N scanty-6 scanty4 scanty7 1 INFIL 24
22 37 M 68 120 130 N 1+ 1+ 1+ 123 INFIL 23
23 43 M 999 155 189 IGT 1+ _ve 1+ 1 123 INFIL INFIL 22
24 38 F 111 138 125 N 1+ 1+ 1+ 2 23 CAVITY INFIL 24
25 38 F 60 80 96 N _ve scanty-6 1+ 1 INFIL 23
26 43 M 85 105 134 N 1+ 1+ 1+ 1 INFIL 20
27 25 F 86 132 105 N 1+ scanty7 scanty8 1 INFIL 21
28 45 M 145 168 203 DM _ve 1+ 1+ 2 CAVITY 29
29 25 F 88 123 134 N _ve 1+ 1+ 1 1 INFIL INFIL 23
30 27 F 75 108 91 N 1+ 3+ 3+ 1 INFIL 22
31 26 M 73 174 167 IGT 1+ 1+ 1+ 1 INFIL 24
32 27 M 120 132 136 IFG 1+ _ve _ve 1 CAVITY 23
33 40 M 77 98 80 N 1+ 1+ 1+ 1 CAVITY 22
34 29 M 90 144 156 IGT 1+ 1+ 1+ 1 CAVITY 21
35 42 F 62 112 77 N _ve 1+ 1+ 1 INFIL 22
36 44 M 90 173 196 IGT 3+ 3+ 3+ 3 HYDROP 22
37 37 M 79 111 130 N _ve 1+ 1+ 1 INFIL 22
38 26 M 89 146 158 IGT 2+ 2+ 2+ 123 123 INFIL INFIL 23
39 25 M 78 123 128 N 2+ 2+ 1+ 13 123 CAVITY 21
40 45 M 111 284 264 DM 1+ 3+ 3+ 1 INFIL 27
41 40 M 90 123 134 N 1+ 1+ scanty9 1 CON 22
42 45 M 88 189 203 DM 3+ 3+ 3+ 123 123 INFIL INFIL 26
43 25 F 87 119 109 N 1+ 1+ 1+ 1 1 INFIL INFIL 21
APPENDIX III             
 MASTER CHART
Sl.NO AGE SEX B.S.F 1HrPP 2HrPP ADA Gr.
SPUTUM
A
SPUTUM
B
SPUTUM
C ZONER ZONEL LESIONR LESIONL BMI
44 25 F 70 135 169 IGT _ve 1+ 1+ 12 INFIL 22
45 43 M 79 110 134 N _ve 2+ 1+ 1 INFIL 23
46 35 M 74 114 108 N 1+ 1+ 1+ 1 INFIL 21
47 44 M 88 151 177 IGT 1+ 1+ 1+ 1 CAVITY 20
48 25 F 78 120 123 N _ve 1+ 1+ 2 CAVITY 23
49 45 M 78 177 202 DM 1+ 2+ 2+ 1 INFIL 26
50 45 M 87 112 134 N 1+ 1+ 1+ 1 CAVITY 21
51 34 M 134 206 234 DM 3+ 3+ 3+ 1 INFIL 28
52 43 M 90 195 201 DM 1+ 1+ 1+ 123 123 INFIL INFIL 25
53 43 M 114 165 188 IGT 1+ 1+ 1+ 1 INFIL 22
54 27 F 404 304 216 DM 1+ 1+ 1+ 1 INFIL 22
55 45 M 89 125 134 N 1+ 1+ 1+ 1 INFIL 23
56 45 F 98 183 206 DM _ve 2+ 1+ 2 CAVITY 26
57 45 M 87 145 165 IGT 3+ 3+ 2+ 1 INFIL 24
58 26 F 75 154 144 N 1+ 1+ 1+ 13 INFIL 21
59 45 M 168 261 263 DM 1+ 1+ 2+ 1 INFIL 23
60 28 M 164 201 388 DM 2+ 2+ 2+ 1 INFIL 21
61 29 M 79 185 168 IGT 2+ 2+ 2+ 1 1 INFIL INFIL 21
62 32 M 88 156 188 IGT 3+ 1+ 1+ 1 INFIL 24
63 43 M 69 125 135 N _ve 1+ 1+ 3 CON 21
64 35 F 86 114 124 N 1+ 1+ 1+ EFF EFF 23
65 39 F 82 123 114 N 1+ 1+ 1+ 1 CAVITY 23
66 40 M 96 156 187 IGT 1+ 1+ 1+ 1 INFIL 21
67 43 M 125 114 120 IFG 1+ 1+ 1+ 1 INFIL 20
68 41 F 99 135 124 N _ve 1+ 1+ 1 INFIL 22
69 26 F 104 125 134 N 1+ 1+ _ve 1 INFIL 23
70 42 M 94 156 192 IGT 1+ 1+ 1+ 1 INFIL 21
71 44 M 84 115 127 N 1+ 2+ 1+ 1 INFIL 21
72 28 F 114 128 136 IFG 1+ 1+ 1+ 12 INFIL 20
73 36 M 89 136 166 IGT 1+ 1+ 2+ 3 CON 22
74 44 F 86 125 132 N 1+ 2+ 1+ 1 INFIL 24
75 41 M 98 125 133 N 1+ 1+ 1+ 1 INFIL 23
76 39 M 74 145 169 IGT 1+ 1+ 1+ 1 INFIL 21
77 33 F 86 124 132 N 1+ 1+ 1+ 1 INFIL 22
78 35 M 89 125 136 N 1+ 1+ 2+ 1 CAVITY 21
79 42 M 102 145 186 IGT 1+ 1+ 1+ 1 INFIL 23
80 44 M 115 186 225 DM 3+ 2+ 2+ 1 INFIL 26
81 28 F 98 128 126 N 1+ 1+ 1+ 1 INFIL 21
82 33 F 88 154 168 IGT 1+ 1+ 1+ 1 INFIL 22
83 35 F 99 156 178 IGT 1+ 1+ 1+ 1 INFIL 23
84 39 M 114 168 229 DM 3+ 3+ 2+ 1 INFIL 25
85 41 M 96 114 125 N 1+ 1+ 1+ 1 CAVITY 22
86 40 M 129 179 231 DM 2+ 1+ 2+ 1 CAVITY 27
87 43 M 74 106 114 N _ve 1+ 1+ 1 INFIL 22
88 26 F 124 135 126 N _ve 1+ 1+ 1 INFIL 20
89 29 M 77 128 134 N 1+ 1+ 1+ 12 INFIL 23
90 30 M 100 149 171 IGT 2+ 2+ 1+ 1 INFIL 23
Sl.NO AGE SEX B.S.F 1HrPP 2HrPP ADA Gr.
SPUTUM
A
SPUTUM
B
SPUTUM
C ZONER ZONEL LESIONR LESIONL BMI
91 25 M 84 124 132 N 1+ 1+ 1+ CON 22
92 35 M 96 125 135 N 1+ 1+ 1+ 1 INFIL 21
93 33 F 96 147 168 IGT 1+ 1+ 1+ 1 INFIL 24
94 27 M 84 125 136 N 1+ 1+ 1+ 1 CAVITY 22
95 37 M 92 105 124 N 1+ 1+ _ve 1 INFIL 21
96 32 F 93 135 167 IGT 3+ 1+ 1+ 1 INFIL 22
97 41 M 125 169 245 DM 2+ 2+ 1+ 12 INFIL 25
98 35 F 96 112 125 N 1+ 1+ 1+ 3 CON 22
99 45 F 128 184 268 DM 2+ 2+ 1+ 1 INFIL 25
100 25 M 78 115 137 N 1+ 1+ 1+ 3 CON 23
101 26 F 84 114 125 N 1+ 1+ 1+ 1 INFIL 21
102 31 M 112 126 135 IFG 1+ 1+ 1+ 1 INFIL 22
103 30 M 95 125 135 N 1+ 1+ 1+ 123 INFIL 21
104 26 M 86 124 134 N 1+ 1+ 1+ 1 1 INFIL INFIL 23
105 42 M 112 158 163 IGT 3+ 1+ 2+ 1 1 CAVITY INFIL 25
106 44 F 96 154 178 IGT 1+ 1+ 1+ 1 1 INFIL INFIL 23
107 41 F 112 158 225 DM 2+ 2+ 1+ 3 CON 25
108 43 M 95 158 194 IGT 3+ 1+ 1+ EFF EFF 25
109 29 M 88 102 124 N 1+ 1+ 1+ 1 INFIL 21
110 35 M 76 131 135 N 1+ 1+ 1+ 12 INFIL 21
111 39 F 95 145 168 IGT 1+ 2+ 1+ 1 INFIL 24
112 38 M 91 125 146 IGT 1+ 1+ 1+ EFF 24
113 26 M 88 124 135 N 1+ 1+ 1+ 3 CON 21
114 29 F 124 135 126 IFG 1+ 1+ 1+ HYDROP 23
115 35 M 95 125 134 N 1+ 1+ 1+ 1 INFIL 22
116 42 M 121 158 177 IGT 1+ 1+ 2+ 1 1 INFIL INFIL 24
117 44 F 152 198 257 DM 3+ 1+ 1+ 1 CAVITY 26
118 38 M 89 124 134 N 1+ 1+ 1+ 1 CAVITY 22
119 35 F 95 145 175 IGT 2+ 2+ 1+ 1 INFIL 25
120 27 M 88 121 136 N 1+ 1+ 1+ 1 1 INFIL INFIL 21
121 43 M 124 165 239 DM 1+ 1+ 1+ 12 INFIL 24
122 42 M 94 135 168 IGT 2+ 1+ 2+ 1 1 INFIL INFIL 24
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